Chee Khoon Lee

18PUBLICATIONS
119CO-AUTHORS
Predictive and prognostic markersTumour immunologyPacific Peoples nursingCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|Apr 28, 2026
Heterogeneity of treatment effect? What baseline prognostic factors tell us about immunotherapy benefit.

|Mar 09, 2026
Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

Jhanelle E Gray, Konstantin Laktionov, Sang-We Kim

|Feb 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.

Rachel Woodford, Sally Lord, Tom John

|Nov 05, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

|Jun 09, 2025
Navigating advanced lung cancer care, patient-physician alliance, cancer stigma, and psychosocial support in Asia-Pacific: perspectives from patients, caregivers, and physicians.

Chee Khoon Lee, Xue Yang, Yasushi Goto

Pageof 3

Frequent Collaborators

5 joint publications

Sarah J Lord

5 joint publications

R John Simes

4 joint publications

James Chih-Hsin Yang

4 joint publications

Michael L Friedlander